Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Consuelo Gajate

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Physical Chemistry. B|August 21, 2008
Edelfosine is incorporated into rafts and alters their organizationAlessio Ausili, Alejandro Torrecillas, Francisco J Aranda, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2009
Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitisFaustino Mollinedo, Consuelo Gajate, Ana I Morales, et al.
The Journal of Experimental Medicine|August 4, 2004
Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosisConsuelo Gajate, Esther Del Canto-Jañez, A Ulises Acuña, et al.
International Journal of Pharmaceutics|April 21, 2006
Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranesAlejandro Torrecillas, J Daniel Aroca-Aguilar, Francisco J Aranda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 24, 2024
Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosineVerónica Alonso-Pérez, Vanessa Hernández, Marco A Calzado, et al.
Journal of Medicinal Chemistry|January 22, 2005
Further naphthylcombretastatins. An investigation on the role of the naphthalene moietyAna B S Maya, Concepción Pérez-Melero, Carmen Mateo, et al.
Pharmacology & Therapeutics|June 12, 2016
Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapyPaul-Alain Jaffrès, Consuelo Gajate, Ana Maria Bouchet, et al.
Chemistry & Biology|November 22, 2005
DNA and non-DNA targets in the mechanism of action of the antitumor drug trabectedinMarie-Hélène David-Cordonnier, Consuelo Gajate, Osvaldo Olmea, et al.
Plos Neglected Tropical Diseases|August 23, 2017
Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosineJanny A Villa-Pulgarín, Consuelo Gajate, Javier Botet, et al.
The Journal of Pathology|June 6, 2020
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomibSilvia Sevilla-Movilla, Nohemí Arellano-Sánchez, Mónica Martínez-Moreno, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Physical Chemistry. B|August 21, 2008
Edelfosine is incorporated into rafts and alters their organizationAlessio Ausili, Alejandro Torrecillas, Francisco J Aranda, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2009
Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitisFaustino Mollinedo, Consuelo Gajate, Ana I Morales, et al.
The Journal of Experimental Medicine|August 4, 2004
Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosisConsuelo Gajate, Esther Del Canto-Jañez, A Ulises Acuña, et al.
International Journal of Pharmaceutics|April 21, 2006
Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranesAlejandro Torrecillas, J Daniel Aroca-Aguilar, Francisco J Aranda, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 24, 2024
Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosineVerónica Alonso-Pérez, Vanessa Hernández, Marco A Calzado, et al.
Journal of Medicinal Chemistry|January 22, 2005
Further naphthylcombretastatins. An investigation on the role of the naphthalene moietyAna B S Maya, Concepción Pérez-Melero, Carmen Mateo, et al.
Pharmacology & Therapeutics|June 12, 2016
Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapyPaul-Alain Jaffrès, Consuelo Gajate, Ana Maria Bouchet, et al.
Chemistry & Biology|November 22, 2005
DNA and non-DNA targets in the mechanism of action of the antitumor drug trabectedinMarie-Hélène David-Cordonnier, Consuelo Gajate, Osvaldo Olmea, et al.
Plos Neglected Tropical Diseases|August 23, 2017
Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosineJanny A Villa-Pulgarín, Consuelo Gajate, Javier Botet, et al.
The Journal of Pathology|June 6, 2020
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomibSilvia Sevilla-Movilla, Nohemí Arellano-Sánchez, Mónica Martínez-Moreno, et al.
Pageof 6